Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD
- DOI
- 10.1152/ajplung.00237.2025
- Published
- 2026-02-01
- Container
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1152/ajplung.00237.2025,
title = {Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD},
author = {Barsha Baisakhi Nayak and Thomas Bärnthaler and Rishi Rajesh and Julia Teppan and Theresa Gogg and Philipp Douschan and Nikolaus Kneidinger and Anne M. van der Does and Pieter S. Hiemstra and Akos Heinemann and Eva Maria Böhm},
year = {2026},
journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
doi = {10.1152/ajplung.00237.2025},
url = {https://doi.org/10.1152/ajplung.00237.2025}
}RIS
TY - JOUR TI - Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD AU - Barsha Baisakhi Nayak AU - Thomas Bärnthaler AU - Rishi Rajesh AU - Julia Teppan AU - Theresa Gogg AU - Philipp Douschan AU - Nikolaus Kneidinger AU - Anne M. van der Does AU - Pieter S. Hiemstra AU - Akos Heinemann AU - Eva Maria Böhm PY - 2026 JO - American Journal of Physiology-Lung Cellular and Molecular Physiology DO - 10.1152/ajplung.00237.2025 UR - https://doi.org/10.1152/ajplung.00237.2025 ER -
APA
Nayak, B. B., Bärnthaler, T., Rajesh, R., Teppan, J., Gogg, T., Douschan, P., Kneidinger, N., Does, A. M. V. D., Hiemstra, P. S., Heinemann, A., & Böhm, E. M. (2026). Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD. American Journal of Physiology-Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.00237.2025
Source records
- crossref · retrieved 2026-09-27T03:16:21.054Z